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at Human Innate Immunity Genes
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Jean-Laurent Casanova,4,5,6,7,8 Etienne Patin,1,2 and Lluis Quintana-Murci1,2,*
Human genes governing innate immunity provide a valuable tool for the study of the selective pressure imposed by microorganisms on
host genomes. A comprehensive, genome-wide study of how selective constraints and adaptations have driven the evolution of innate
immunity genes is missing. Using full-genome sequence variation from the 1000 Genomes Project, we first show that innate immunity
genes have globally evolved under stronger purifying selection than the remainder of protein-coding genes.We identify a gene set under
the strongest selective constraints, mutations in which are likely to predispose individuals to life-threatening disease, as illustrated by
STAT1 and TRAF3. We then evaluate the occurrence of local adaptation and detect 57 high-scoring signals of positive selection at innate
immunity genes, variation in which has been associated with susceptibility to common infectious or autoimmune diseases. Further-
more, we show that most adaptations targeting coding variation have occurred in the last 6,000–13,000 years, the period at which pop-
ulations shifted from hunting and gathering to farming. Finally, we show that innate immunity genes present higher Neandertal intro-
gression than the remainder of the coding genome. Notably, among the genes presenting the highest Neandertal ancestry, we find the
TLR6-TLR1-TLR10 cluster, which also contains functional adaptive variation in Europeans. This study identifies highly constrained
genes that fulfill essential, non-redundant functions in host survival and reveals others that are more permissive to change—containing
variation acquired from archaic hominins or adaptive variants in specific populations—improving our understanding of the relative bio-
logical importance of innate immunity pathways in natural conditions.Introduction
The burden of infectious diseases has been massive
throughout human history, particularly before the advent
of hygiene, vaccines, antiseptics, and antibiotics, when
human populations were ravaged by illnesses that resulted
in high childhood mortality and short life expectancy.1 In
light of this, and given that the human genetic makeup
strongly influences an individual’s susceptibility to infec-
tious disease and the resulting clinical outcome,2,3 natural
selection imposed by pathogens is expected to have pro-
foundly affected the patterns of variability of the human
genome.4–7 Indeed, interspecies analyses and within-
species studies in humans have established that purifying
and positive selection have been pervasive among both
genes and functions related to immunity and host de-
fense.5,8–14 Furthermore, pathogen pressure is increasingly
recognized as the underlying cause of such selection signa-
tures, with many immunity-related genes presenting pat-
terns of variation that strongly correlate with pathogen
diversity.15
Over recent decades, the dissection of the form and in-
tensity of selection in the human genome has established
the value of population genetics as a complement to clin-
ical and epidemiological genetic studies, in delineating
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Thein predicting their involvement in disease.2,4,7,16 Genes
evolving under strong purifying selection are predicted to
include those involved in essential mechanisms of host
defense, variation in which should lead to severe disor-
ders.16 This prediction is supported by genome-wide
data, because Mendelian disease genes are enriched in sig-
nals of purifying selection.8,9,17 Conversely, genes evolving
adaptively—through positive or balancing selection (e.g.,
HBB [MIM: 141900], DARC [MIM: 613665], FUT2 [MIM:
182100], the HLA locus genes, ABO blood group genes,
and TRIM5 [MIM: 608487])—are usually more permissive
to functional variation, which can exert a protective effect
against infections.2,4,7,18 These signals of adaptive evolu-
tion in immune-related genes, tending to be recent and
population specific, further emphasize the important role
of pathogens in local adaptation.
Besides the occurrence of novel mutations, functional
variants transmitted through admixture represent another
potential source of adaptive variation. Recent data
provided evidence that 1%–6% of modern Eurasian ge-
nomes were inherited from ancient hominins, such as
Neandertals or Denisovans,19–21 with specific genomic re-
gions presenting up to 64% of Neandertal ancestry.22 In
the context of immunity, there is increasing evidence to
suggest that modern humans have acquired advantageous
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documented by candidate gene approaches for HLA class I
genes, STAT2 (MIM: 600556), or the OAS gene cluster
(MIM: 164350, 603350).23–25
Among the two arms that form the immune system,
innate immunity constitutes the front line of host defense
and provides a valuable model for the study of the selective
pressure imposed by microorganisms—pathogenic and
symbiotic—on host genomes.2,26 Innate immunity relies
on receptors that sense conserved microbial patterns or
molecules and activate signaling pathways that involve
the coordinated action of an array of downstream mole-
cules, including adaptors, regulators, transcription factors,
and effector molecules, all of which are required for the
eradication of pathogens and to maintain homeostasis.27
Importantly, unlike adaptive immunity whose parameter
variation is mostly somatic and presents limited heritabil-
ity, variation of innate immunity is germline encoded and
thus needs to be best-adapted to ensure host survival.28,29
Population genetic studies have shown that the impact of
selection on some families of innate immune receptors and
downstream signaling molecules (e.g., Toll-like receptors,
interferons, or antimicrobial peptides) varies consider-
ably,14,30–43 helping to delineate the relative functional
importance of different immune pathways.2,26 However,
these studies have focused on specific candidate genes or
gene families. A comprehensive, genome-wide view of
how selection has driven the evolution of innate immu-
nity in humans is thus missing.
Here, we took advantage of population whole-genome
sequence data to increase our understanding of the degree
of essentiality and adaptability of the different genes gov-
erning innate immunity and thus, to provide novel in-
sights into their respective biological relevance in host sur-
vival. To do so, we first created a hand-curated list of more
than 1,500 genes belonging to the different modules
constituting the innate immune system in humans (Mate-
rial and Methods). We then analyzed their patterns of pop-
ulation genetic variability, which we compared to the
remainder of the genome, using the 1000 Genomes Project
dataset,44 allowing us to evaluate the occurrence and in-
tensity of constraint and adaptation to geographic and
environmental pressures with an unprecedented level of
resolution. Finally, we estimated the time range at which
the bulk of genetic adaptation involving innate immunity
has occurred and evaluated the extent to which human
populations have acquired innate immunity genetic varia-
tion through admixture with Neandertals.Material and Methods
Hand-Curated List of Innate Immunity Genes
We created a hand-curated list of innate immunity genes (IIGs) by
combining two public databases, Gene Ontology (GO)45 and
InnateDB,46 as well as by incorporating missing entries. Specif-
ically, we used the GO term ‘‘innate immune response’’ (GO:
0045087) to extract 1,309 entries corresponding to 884 unique an-
notations (last access January 2015). We removed all non-human6 The American Journal of Human Genetics 98, 5–21, January 7, 2016taxon entries, non-SwissProt reviewed proteins, entries without
gene symbol or not approved by the HUGO Gene Nomenclature
Committee, as well as those encoding for HLA proteins and immu-
noglobulins. This yielded a final set of 806 GO genes. For
InnateDB, we retrieved 2,158 entries, corresponding to 989
unique annotations (last access January 2015). Similarly to GO,
we removed entries without approved HUGO names, HLA genes,
and miRNAs, and obtained a final set of 905 InnateDB genes.
When manually reviewing these two gene lists, we noticed the
presence of proteins belonging, based on structural homology, to
gene families that are commonly accepted to play a role in innate
immune processes (e.g., Nod-like receptors), even if the involve-
ment of some of their individual members in innate immunity re-
mains unclear. Because GO and InnateDB did not systematically
use this ‘‘family-based criteria,’’ we manually did so for gene fam-
ilies in which some of their individual members were missing
(e.g., we added 28 TRIM proteins and 24 C-type lectins). In addi-
tion, we noticed the absence of several well-described or recently
identified molecules, including some nucleic acid sensors such as
ABCF1 (MIM: 603429), DHX15 (MIM: 603403), DHX33 (MIM:
614405), and PYHIN1 (MIM: 612677). By applying these inclusion
criteria, we also retrieved some of the filteredGO and InnateDB en-
tries that were initially removed because they were present under a
non-approvedHUGO symbol. This was the case for the interferons
IFNL1 (MIM: 607403), IFNL2 (MIM: 607401), and IFNL3
(MIM: 607402), which were annotated in InnateDB as IL29,
IL28A, and IL28B, respectively. We acknowledge that some mole-
cules that we manually added (which were absent from the lists
that were downloaded from the databases at the time of the study)
have now been included in the corresponding websites. Our
manual inclusion of additional genes, based on current knowledge
of gene families and functions related to innate immunity (e.g.,
missing chemokines, defensins, and caspases; see Table S1), was
an attempt to update existing databases. Overall, we manually
added a set of 187 genes, making a final dataset of 1,553 genes
that constituted the basis of all subsequent analyses (Table S1).
We classified the 1,553 genes according to their main known
(or inferred) function into nine different categories. These include
sensors (n ¼ 274), adaptors (n ¼ 46), signal transducers (n ¼ 245),
transcription factors (n ¼ 93), effector molecules (n ¼ 284), and
secondary receptors (n ¼ 70). We also included regulators of the
signaling pathways (n ¼ 310) and accessory molecules (n ¼ 68)
necessary for an efficient immune response. This classification
was based on the functional information available for each of
these genes in InnateDB, UniProt, and/or the corresponding pub-
lications. Out of the 1,553 genes, 163 remained unclassified,
because their reported molecular description did not allow us to
include them in any of the categories above and were thus group-
ed into a final category termed as ‘‘uncharacterized.’’Whole-Genome Sequence Datasets
Depending on the nature of the analyses performed, we used the
high-coverage (~573) exome sequencing data and/or the low-
coverage (2–63) sequencing data of the 1000 Genomes Project,
which are available for 1,092 individuals from 14 populations
from Europe, East Asia, sub-Saharan Africa, and the Americas.44Assessing the Action of Purifying Selection
Quantification of the Extent of Purifying Selection
To estimate the strength of purifying selection, we used SnIPRE,47
which relies on the comparison of polymorphism and divergence
at synonymous and non-synonymous sites (i.e., McDonald-Kreit-
man contingency table). This method uses a generalized linear
mixed model to model the genome-wide variability among cate-
gories of mutations and estimates two population genetics param-
eters for each gene: g, the population selection coefficient, and f,
the proportion of non-synonymousmutations that are not delete-
rious. We focused our analyses on f, to quantify the strength of
purifying selection: a low f value indicates that a large proportion
of non-synonymous alleles were deleterious and have been
removed from the population. We retrieved the alignment of the
human genome (hg19 release) and the chimpanzee genome (Pan-
Tro3 release), used as an outgroup, provided by the UCSCGenome
Browser, corresponding to ~2.5 Gb of aligned sequences. All re-
gions of the human genome that are deleted or have no homology
with the chimpanzee were excluded from the analysis.
We identified 33.5 million single bases that were different be-
tween the two species, which were then functionally annotated
with SnpEff,48 using the GRCh37.65 build. We obtained 200,676
non-synonymous or synonymous divergent differences between
humans and chimpanzees. We next retrieved all human variants
that have been identified by the 1000 Genomes Project high-
coverage exome dataset.We kept 445,401 variants that were anno-
tated as non-synonymous or synonymous, were outside of gaps in
the human-chimpanzee alignment, and were polymorphic in at
least one human population. Variants with a fixed alternate allele
in the 1000 Genomes Project dataset (i.e., reference allele is absent
from the sample) were added to fixed differences between human
and chimpanzee. We excluded from human-chimpanzee fixed dif-
ferences 16,345 positions that were actually polymorphic in hu-
mans or chimpanzees, using the dbSNP136 chimpanzee database.
We retrieved all human CDS with length >68 bp and considered
the longest transcript available for each gene. We deduced from
the genetic code the number of synonymous and non-synony-
mous sites in the 22,571 transcripts obtained, accounting for
gaps in the human-chimpanzee alignments. Finally, we excluded
all transcripts that had a length <50 bp after accounting for these
gaps, had no divergent nor polymorphic mutations, had no
HUGO-approved gene symbol, or was not a SwissProt ‘‘reviewed’’
protein. HGNC-approved gene symbols were retrieved with the R
BioConductor biomaRt package (v.2.22.0), and SwissProt protein
status were retrieved with the R BioConductor UniProt.ws package
(v.2.6.2). SnIPRE47 was then used to estimate the f parameter for
17,967 genes, which included a final set of 1,492 IIGs, assuming
human and chimpanzee sample sizes of 1,092 and 10,
respectively.
Statistical Analyses
We estimated the enrichments of IIGs among genes evolving un-
der purifying selection by measuring the odds ratios (OR) of pur-
ifying selection. This OR measures the relative proportion of
IIGs among genes with purifying selection signals and is defined
as follows:
OR ¼
"
PðIIG j SELÞ
P

IIG j SEL
#"
P

IIG j SEL
P

IIG j SEL
#
;
with IIG and IIG denoting genes being or not innate immunity
genes, respectively, SEL and SEL being ‘‘with’’ and ‘‘without purify-
ing selection signals,’’ respectively. If purifying selection preferen-
tially targets IIGs, we expect proportionally more IIGs in the tail of
the f distribution (OR> 1). Otherwise, we expect the same amount
of IIGs in the tail of the f distribution as in the remainder of
the genome (OR z 1). Note that all statistical tests comparing fThedistributions among gene classes (e.g., IIGs against the rest of hu-
man genes) were performed (1) assuming statistical independence
between genes (i.e., very weak correlation between f values of
neighboring genes, R2 ¼ 0.016384) and (2) correcting by any po-
tential differences in the distributions of gene length and number
of SNPs per gene observed among classes. Because the f value is
potentially dependent on gene length and/or the number of
SNPs per gene, we corrected for these potential confounders by
performing 105 resamplings where these distributions (gene
length and number of SNPs per gene) were matched between
the tested class (e.g., IIGs) and every resampled set of genes.
Prediction of the Functional Impact of Mutations
To evaluate the fitness status of variants at IIGs, we used the Com-
bined Annotation Dependent Depletion (CADD) algorithm.49 We
downloaded the PHRED-scaled C-score calculation for the
39,701,210 variants (SNPs and indels) from the 1000 Genomes
Project and filtered out mutations that were excluded from the an-
alyses of purifying selection. We then compared the number of
SNPs in IIGs (33,867) and in the remainder of protein-coding se-
quences (399,784) having a PHRED-scaled scoreR 15. We consid-
ered this value as the limit above which mutations are probably
damaging, because this score corresponds to the median value
for all possible canonical splice site changes and non-synonymous
variants.49
Selective Constraints on Genes Associated with Primary Immunodefi-
ciencies
To assess to degree of purifying selection on IIGs associated with
primary immunodeficiencies (PID), we retrieved all known PID
genes from the database compiled by the Expert Committee of
the International Union of Immunological Societies50 and identi-
fied those corresponding to IIGs.We compared the distributions of
f values between the 1,373 non-PID-associated IIGs and the 119
PID-associated IIGs for which the f parameter was available,
considering their mode of inheritance. We considered only genes
for which the mode of inheritance was autosomal dominant (AD)
or autosomal recessive (AR) in a given subgroup of PIDs. Genes
associated to an AD form in a subgroup of PID and to an AR
form in another subgroup of PID were included in both AD and
AR categories.
Protein-Protein Interaction Network Analysis
We reconstructed the protein-protein interaction network by
retrieving the interactions from the BioGRID database
v.3.2.105.51 We retrieved protein Ensembl IDs via BioMart and
considered only non-redundant direct physical interactions to
compute degree centrality with the NetworkAnalyzer plugin52
in Cytoscape.53 Ubiquitin C and amyloid precursor protein
were removed from further analysis because they display outlier
degree centralities. We transformed the degree centrality to
log10(1þdegree centrality) to reduce the skewness of the distribu-
tion and used a Pearson correlation test to evaluate its relation-
ship with the SnIPRE f parameter. We computed this correlation
for the 1,114 IIGs and for the remaining 8,557 protein-coding
sequences for which both degree centrality and f could be
determined. We compared these correlations by using a linear
model to estimate the effect of innate immunity in the relation-
ship between f and degree centrality. For the network representa-
tion, we used our IIG list as input for Cytoscape and retrieved in-
teractions among innate immunity proteins with the MiMI
plugin.54
Transcription, Signal Transduction, and Innate Immunity
We retrieved the list of genes coding for proteins involved in tran-
scription from the Gene Ontology ‘‘transcription, DNA-templated’’American Journal of Human Genetics 98, 5–21, January 7, 2016 7
entry (GO: 0006351). From this list of 2,643 genes, we extracted
the 2,337 genes for which f values were calculated via SnIPRE.
We considered genes at the intersection of this GO list and our
set of IIGs as involved in both innate immune response and tran-
scription. We then compared the distribution of f values between
this group of genes involved in both innate immunity and tran-
scription with that of genes involved only in transcription
processes. Because our set of IIGs also includes entries from
InnateDB, we performed the same analyses by restricting the
comparisons only between the two Gene Ontology terms
‘‘transcription, DNA-templated’’ and ‘‘innate immune response.’’
The same rationale was applied to the comparisons involving
signal transducers; we retrieved a list of 1,875 genes from
the Gene Ontology ‘‘intracellular signal transduction’’ entry
(GO: 0035556) and extracted the 1,695 genes for which SnIPRE
f values were available.Genome-Wide Detection of Positive Selection
Detection of Positive Selection via a Composite Statistics
We combined, for each SNP, the set of statistics used in previous
studies,5,55 based on haplotype homozygosity (iHS,13 DiHH,55
and XP-EHH12) or the degree of population differentiation
(DDAF55 and FST
56). In addition, we incorporated the DIND statis-
tics,14 which has been found to be powerful to detect positive se-
lection using low-coverage sequencing data.57 For statistics based
on haplotype homozygosity, we used the phased data of each
population of the 1000 Genomes Project and sliding windows
of 100 kb centered on each SNP. This procedure does not alter
the power to detect selection and ensures each statistics to be
computed using equivalent regions, in terms of recombination
rate, coverage, and allele frequency spectrum.57 Because some
of these statistics require the ancestral/derived state of mutations,
we retained sliding windows for which the ancestral/derived state
of the core SNPs was unambiguously determined, i.e., 97% of the
mutations of the 1000 Genomes dataset. Finally, we aimed to
minimize the false positive rate, by excluding windows in which
the core SNP had a derived allele frequency (DAF) below 0.2,
because the power to detect selection at this allele frequency is
limited.57
All neutrality statistics were then combined into a Fisher’s com-
bined score (FCS)
FCS ¼ 2
XK
i¼1
ln

pi

where K is the number of combined statistics and pi the empirical
p value for the ith statistics, i.e., the genomic rank of this ith statis-
tics divided by the total number of unique values obtained for this
statistics in the entire genome (values exactly equal get the same
rank and same p value). When pi values tend to be small, the FCS
tends to be large. Under neutrality, FCS has a chi-square distribu-
tion with 2K degrees of freedom. However, because the assump-
tion of dependency among pi is violated, we used the genomic dis-
tribution of FCS in an empirical genome-wide test of selection,
where the candidate SNPs with signals of selection are the ones
exhibiting the 1% highest FCS values, as reported for other statis-
tics.13,57 Note that the FCS is computed for each population
separately.
Statistical Analyses
Enrichments in positive selection signals among specific SNP
classes (e.g., genic, located in IIGs, etc.) were tested as previ-
ously described.8,13,57 Specifically, we used a logistic regression,8 The American Journal of Human Genetics 98, 5–21, January 7, 2016generating an OR for the effect of positive selection. For a given
SNP class, the OR is defined as follows:
OR ¼
"
Pðclass j SELÞ
P

class j SEL
#"
P

class j SEL
P

class j SEL
#
;
with class being the SNP class, e.g., class and class being genic and
non-genic SNPs, respectively, SEL and SEL being ‘‘with’’ and
‘‘without positive selection signal’’ respectively, i.e., SNP with an
extreme FCS value. For example, if positive selection has preferen-
tially occurred in genic regions, an OR > 1 would be expected, re-
flecting an enrichment in genic SNPs among SNPs with extreme
FCS values (e.g., OR ¼ 1.25 when there are 20% true and 80% false
positive among genic SNPs with extreme FCS values
57). Otherwise
(i.e., 100% of false positives among genic SNP outliers), we would
expect an OR ~1, indicating that the proportion of genic SNPs
among outliers is not greater than the expected proportion of
genic SNPs among all SNPs (~38% for the 1000 Genomes Project
datasets57). The p values of enrichment analysis were obtained
from 10,000 independent resamplings, taking into account link-
age disequilibrium (LD) between SNPs.57 For each resampling,
we drew non-overlapping regions of 500 consecutive SNPs and
arbitrarily assigned them to a given class, until we reached the
number of SNPs observed in this SNP class. We considered the re-
maining SNPs to be out of the given class and calculated theOR for
each resampling.57
Identification of Candidate Regions
To identify candidate gene regions evolving adaptively, we used a
conservative approach based on the degree of clustering of SNPs
with extreme FCS values (i.e., the 1% top FCS values).
13,57 We
used sliding windows of 100 kb centered on each SNP that contain
at least 100 variants. We computed, for each 100 kb window, the
proportion of extreme FCS values and grouped these windows
into 75 bins of equal sizes based on the total number of SNPs
observed. Finally, we considered the 1% of windows with the
highest proportion of extreme FCS values in each bin as being un-
der positive selection. A gene is thus considered to be a target of
positive selection if it contains at least one window falling into
this criterion.
Assessing the Power to Detect Selection
To evaluate the power to detect positive selection using the FCS,
we used cosi258 to simulate DNA regions according to realistic,
accepted scenarios of human demography, as previously used
for the 1000 Genomes Project dataset (for details on the parame-
ters of the demographic model used, see Grossman et al.5). We
simulated 60 unrelated individuals in each population sample,
matching the 1000 Genomes Project dataset. We simulated
200-kb DNA regions with recombination rates sampled from
the HapMap recombination map to generate realistic recombina-
tion patterns including local hotspots.59 We simulated neutrally
evolving regions and positive selection assuming the hard sweep
model.60 Specifically, a single new advantageous mutation with
frequency 1/2N was inserted into the middle of the sequence in
a specific population (YRI, CEU, or CHB) at a specific time t,
with a population genetics selection parameter 2Ns ¼ 100 (selec-
tion coefficient s ¼ 0.01, N ¼ 10,000). We simulated different
models of hard sweeps, by specifying various ages t of the selected
allele (5 kya, 10 kya, 20 kya, and 30 kya) and various psel, i.e., the
frequency of the selected allele in the current generation (0.2, 0.4,
0.6, 0.8, and 1.0). We simulated 1,000 neutral-evolving regions
and 100 regions for each combination of selection parameters
(t, s, and psel).
Because we used 100-kb windows centered on each SNP in the
real data, and to avoid any truncation of these windows, we
trimmed all simulated SNPs located at less than 50 kb of the edges
of the 200 kb simulated regions. We computed the FCS for each re-
tained SNP located in the 100 kb in the middle of the 200 kb simu-
lated region. We normalized iHS and DIND via the same method
as previously described.13,57 The empirical p value pi used in the
computation of FCS was determined for each population sepa-
rately, using all neutral simulations. We detected simulated re-
gions under positive selection on the basis of the proportion of
extreme FCS values. The power to detect positive selection was
then computed as the proportion of regions simulated under pos-
itive selection effectively detected by our statistics (i.e., the per-
centage of simulations presenting proportions of extreme FCS
values above the neutral threshold defined for a FPR of 1%).
Annotation using GWAS Hits and Immune-Related eQTLs
For the 57 IIGs presenting signatures of positive selection
(i.e., innate immunity genes carrying at least one SNP whose win-
dow has a proportion of outlier FCS among the 1% of genome-wide
windows), we explored their involvement in diseases or traits by
using hits of genome-wide association studies (GWASs) and
expression quantitative trait loci (eQTLs) data. For the GWAS ana-
lyses, we used the data from the 02/06/2015 version of the NHGRI
database and only GWAS signals with p values lower than 53 108
were considered. We used two approaches: the first (gene-based)
approach relies on the fact that the tested IIG is the reported
gene of a GWAS hit. The second (SNP-based) approach considers
equivalence or strong LD between candidate SNPs for positive se-
lection and SNPs reported as best GWAS hits. For this second LD-
aware approach, we selected all outlier SNPs (i.e., FCS among the
1% of genome-wide windows) in the genomic region of the tested
IIG. We then retrieved all SNPs in strong LD (r2 > 0.8) with any of
these candidate SNPs, using the correlation coefficient imple-
mented in Plink61 on the unphased 1000 Genomes Project data
for the relevant population (i.e., that where the FCS signal was
maximal). We finally checked whether some of our candidate
SNPs for positive selection, or any SNP in LD with them, were
among GWAS best signals. For the eQTL data, we used the same
SNP-based approach to identify candidate positively selected
SNPs that have been previously associated with the expression
of surrounding genes in purified, stimulated monocytes (i.e.,
21,516 eQTLs from Fairfax et al.62). We considered only the best
p value obtained across stimulation conditions (FDR < 0.05).ABC Estimation of the Age of Selection
We used an approximate Bayesian computation (ABC) approach63
to estimate the posterior probability of the age of selection of
candidate mutations according to the model described above,
i.e., a new advantageous mutation, occurring at a frequency of
1/2N, in a specific population, at a specific time t. We simulated
200-kb regions with a selected SNP located in the center of the
sequence, according to the demographic model and recombina-
tion patterns described above. To generate a set of 2 3 105 simula-
tions, we used uniform prior distributions for the age and intensity
of selection and for the current frequency of the selected allele: the
age of selection (t) varies from 0 to 62,500 years, the intensity of
selection (s) varies from 0.002 to 0.05, and the current frequency
of the selected allele (psel) from 0.2 to 1.0. Note that the prior dis-
tributions of the age and intensity of selection do not remain
uniform because some parameter vectors (t, s, psel) are unlikely
(e.g., ancient selective events of strong intensity cannot generateThea frequency of the selected allele equal to 0.2). Finally, we also
simulated the low-coverage nature of the data (53) by randomly
drawing limited numbers of reads.57
We initially used a set of summary statistics (ƟS, Ɵp, Tajima’s D,
Fay and Wu’s H, iHS, and FST) that are informative for estimating
age of selection in an ABC framework,64 to which we incorporated
the DIND statistics.14,57 As performed for iHS and DIND, ƟS, Ɵp,
Tajima’s D, and Fay and Wu’s H were computed in a window of
100 kb around the selected mutation. We tested the performance
of various sets of summary statistics with different ABCmethods—
ridge and neuralnet—implemented in the ‘‘abc’’ R package. We
validated the performance of the ABCmethods by using simulated
datasets as if they were true empirical data, for which parameter
values to estimate are known. This procedure allowed us to
compare the estimated to the true values via various accuracy
indices: the prediction error PE (i.e., the mean square error
[MSE], divided by the prior variance of the parameter), the relative
estimation bias rEB (i.e., the bias expressed a proportion of the true
value, also known as relative error), and the coverage of the 95%
credible interval (95% COV) (i.e., the percent of times where the
true value was found within the 95% credible interval). Let qk
and bqk be the true and the ABC estimated values of the parameter
q in the kth simulated dataset:
PE ¼
1
S
PS
1
 bqk  qk2
varðqÞ ;
rEB ¼ 1
S
XS
1
 bqk  qkqk;
95%COV ¼ 1
S
XS
1
1ðq1 < qk < q2Þ;
where S is the number of simulated data, 1(C) the indicative
function (equal to 1 when C is true, 0 otherwise), and q1
and q2 the two percentiles of the posterior distribution of bqk
(q1 and q2 were adjusted to obtain 95% COV approximately
equal to 0.95). These accuracy indices were computed using S
equal to 300 simulated data. Note that the posterior distribu-
tions were obtained by retaining the 1,000 ‘‘best’’ simulations
in the ABC procedure.
We next aimed to improve the ABC estimations by adding more
summary statistics. We first used the summary statistics described
above (‘‘set 1 of summary statistics’’) as well as their corresponding
average and proportion of 1% top values computed over 100 kb
around each candidate variant (‘‘set 2 of summary statistics’’).
Furthermore, we aimed to boost the ABC estimations by including
arithmetic transformations of the used summary statistics.65 Spe-
cifically, we applied to the set 2 of summary statistics the following
transformation, T(SiSjRi) with Si and Sj the i
th and jth summary sta-
tistics. This procedure generated a new set of summary statistics
(‘‘set 3 of summary statistics’’) that were used in the neuralnet
ABC method, which will be referred to as the boosted-neuralnet
ABC method.Analysis of Neandertal Ancestry
To investigate introgression from archaic hominins to modern
humans at IIGs, we used the probabilities of Neandertal ancestry
calculated for each SNP of the 1000 Genomes Project dataset.22
These probabilities were obtained using a conditional random
field method, which takes into account the allelic state at a SNPAmerican Journal of Human Genetics 98, 5–21, January 7, 2016 9
in non-African, Neandertal, and Yoruba individuals, the relative
sequence divergence between these individuals and the consis-
tency of haplotype lengths with estimated time of interbreeding
with archaic humans.22 We downloaded the inferred Neandertal
ancestry at each allele and used the reported combined results
across the CEU, GBR, FIN, IBS, and TSI populations as representing
Europeans (EUR) and CHB, CHS, and JPT as representing East
Asians (ASN).
We calculated the average introgression score for each protein-
coding gene (i.e., removing open reading frames and genes en-
coding for putative proteins) as the average of the marginal prob-
abilities of Neandertal ancestry for all bases of the gene. We then
compared the distributions of the average introgression scores for
our set of IIGs and the remainder of protein-coding genes. p
values between distributions were obtained from 106 indepen-
dent resamplings, taking into account the genomic correlation
of average introgression scores. To this end, we retrieved genomic
regions showing high probability to be introgressed from Nean-
dertal for each population, defined as runs of SNPs that have a
probability of Neandertal ancestry > 0.9. We calculated the me-
dian length of contigs (called mlc) obtained by constructing a
tiling path across confidently inferred Neandertal haplotypes in
each population as described in Sankararaman et al.22 We
divided the genome in adjacent windows of length mlc and as-
sessed the distribution of the number of protein-coding genes
and IIGs by window. Resamplings were carried out taking into ac-
count the distribution of number of IIGs by window. We used
the resampled datasets to obtain the expected distribution of
Mann-Whitney U under the null hypothesis and calculate the
empirical p values.
Finally, we determined the 5% of genes harboring the highest
probability of Neandertal ancestry at the genome-wide level
and searched for those that corresponded to IIGs. These latter an-
alyses were restricted to the CEU and CHB populations, because
they were those used to detect positive selection in modern hu-
mans. For the haplotype analyses, we retrieved confidently in-
ferred Neandertal haplotypes, i.e., runs of SNPs that present a
probability of Neandertal ancestry > 0.9 (see Sankararaman
et al.22).Results
Building of the Innate Immunity Gene List
We established a list of innate immunity genes (IIGs) by
combining two publicly available databases, Gene
Ontology (GO) and InnateDB,45,46 which we manually
curated according to a number of criteria listed in Material
and Methods. This yielded a curated set of 806 genes from
GO and 905 from InnateDB, 345 of which were overlap-
ping (Figure S1A). Furthermore, we incorporated an addi-
tional set of 187 genes that were missing from these data-
sets at the time of the study, making a final list of 1,553
IIGs (Table S1). We then classified all IIGs according to
their main known (or inferred) function into nine different
categories, ranging from sensors of microorganisms or
danger signals to adaptor and effector molecules, and we
also included regulators of the signaling pathways and
accessory molecules necessary for an efficient immune
response (Figure S1B).10 The American Journal of Human Genetics 98, 5–21, January 7, 201Pervasive Signatures of Purifying Selection at Innate
Immunity Genes
To define the degree of selective constraint at IIGs, we first
investigated the extent to which purifying selection has
acted on the different categories of IIGs since the diver-
gence of human and chimpanzee lineages. To do so, we
used the exome dataset from the 1000 Genomes Proj-
ect44 and merged all individuals into a single group to
focus on the human lineage. For all protein-coding se-
quences, where we applied the same filtering criteria as
those applied to IIGs (Material andMethods), we estimated
the f parameter via SnIPRE,47 which estimates the degree of
selective constraints at each gene by using polymorphism
and divergence data at non-synonymous and synonymous
sites. The lower the f value, the stronger the deficit of non-
synonymous mutations compared to synonymous
variants, highlighting strong evolutionary constraints
(Table S1).
We found that the distribution of the f parameter
for IIGs was significantly skewed toward lower values
(Figure 1A; resampling p < 4.7 3 103 considering gene
length and number of SNPs per gene). Similar results
were obtained when performing the analyses with
the GO and InnateDB gene lists separately (resampling
p < 7.6 3 104 and p < 2.7 3 103, respectively),
indicating that our inclusion criteria of IIGs have nomajor
impact on our conclusions. This suggests that
genes involved in innate immune processes eliminate pro-
portionally more non-synonymous variants than
the remainder of protein-coding genes. When restricting
the analyses to genes presenting the lowest f values at
the genome-wide level, we observed a systematic enrich-
ment in IIGs using different percentiles (Figure 1B). For
example, when focusing on genes displaying the 1%
lowest f values, we observed a strong, significant enrich-
ment in IIGs (OR ¼ 2.42, resampling p < 4 3 105), corre-
sponding to the set of IIGs that have evolved under the
strongest degree of purifying selection (Table 1). Such a
significant enrichment was also observed when consid-
ering the different populations separately (OR > 1.82, re-
sampling p < 9.3 3 104), consistent with the high corre-
lations observed between population-specific and species-
wide f values (Figure S2). This suggests that the degree of
purifying selection on IIGs is similar across populations
and independent of recent variation in environmental
pressures.
To test the functional impact of variation at IIGs on pro-
tein structure or function, we first evaluated the deleteri-
ousness of exonic variants by using the PHRED-scaled
C-scores provided by CADD.49 Interestingly, the propor-
tion of variants with a scaled C score R 15 (i.e., among
the ~3% most deleterious mutations of the genome) was
lower in IIGs compared to non-IIGs (0.425 and 0.463,
respectively; p¼ 2.13 1041; Figure S3A), a pattern consis-
tently observed along the site frequency spectrum, with
the exception of high-frequency alleles (Figure S3B). We
next tested whether IIGs known to be involved in severe6
Figure 1. Varying Degrees of Selective Constraints Targeting Innate Immunity Genes
(A) Strength of purifying selection acting on innate immunity genes and the remainder of protein-coding genes, as measured by the f
value. We tested the significance of the observed difference bymeans of 105 resamplings taking into account gene length and number of
SNPs per gene in the two tested gene sets (***p < 4.7 3 103).
(B) Enrichment of innate immunity genes among themost constrained genes at the genome-wide level, as assessed by odds ratios (ORs).
We calculated ORs for increasing percentiles of the f distribution, with a pace of 1%. The 95% confidence intervals of ORs were calculated
via the Fisher’s exact test.
(C) Strength of purifying selection acting on the different functional categories of innate immunity genes, as measured by the f value
(UC stands for unclassified).
(D) Innate immunity protein interaction network. Only innate immunity proteins interacting with a molecular partner also involved in
this cellular process are represented. Node sizes are negatively correlated to f values, i.e., large nodes represent low f values, indicating
stronger action of purifying selection. Color codes are the same as those used in (C).diseases such as primary immunodeficiencies (PID)
were under stronger selective constraints than the
remainder of IIGs. Although no significant differences
were observed between the global distributions of the f
parameter, IIGs associated with autosomal-dominant
forms of PID presented significantly lower f values (resam-
pling p < 1.5 3 102) than the remainder of IIGs
(Figure S4).
We next assessed whether the global signal of strong
purifying selection at IIGs differed among genes with
distinct functional roles in innate immunity. A strongly
significant difference was detected (Kruskal-Wallis rank
sum test p < 2.2 3 1016; Figure 1C). Molecules involved
in signal transduction and transcription were those pre-
senting the strongest selective constraints. Such con-
straints could indicate the additional involvement of these
genes in functions other than innate immunity. To test
this hypothesis, we compared the f values of the ‘‘signalThetransduction’’ and ‘‘transcription’’ groups of IIGs with
those of signal transducers and transcription factors that
are not part of innate immunity processes. Innate immu-
nity molecules involved in these processes presented
significantly lower f values than their respective compari-
son groups (Figure S5), suggesting that their involvement
in innate immunity has further constrained their evolu-
tion. We also observed that sensor and effector molecules
presented the greatest range of f values (Figure 1C), indi-
cating that the degree of constraint affecting these cate-
gories varies among their members. For example, when
comparing the f values among the different sub-families
of receptors, we found that the family of cytosolic nucleic
acid sensors (CNASs) displays the strongest deficit of non-
synonymous mutations (Kruskal-Wallis rank sum test
p ¼ 2.9 3 103), whereas RIG-I-like receptors (RLRs) were
those evolving under the most relaxed selective con-
straints (Figure S6).American Journal of Human Genetics 98, 5–21, January 7, 2016 11
Table 1. Innate Immunity Genes Presenting the Strongest
Signatures of Purifying Selection at the Genome-wide Level
Functional Category Genes
Sensors DHX9
Adaptors CNKSR2, CTNNB1, SRC, SYK
Signal transducers CAMK2B, MTOR, TRAF3
Transcription GATA3, HNRNPL, SMARCA2, SMARCA4,
STAT1
Effectors AGO1, AGO2, AGO3
Secondary receptors EGFR
Accessory molecules HSP90AB1, UBC
Regulators CYLD, HDAC1, KHSRP, MID2, USP7
UC ACTB, ACTG1, CYFIP2, DOCK1, FSCN1,
ITPR1, NCKAP1, TUBB4BFinally, we tested whether the varying degree of selective
constraints detected at the different IIGs could be partly
explained by their localization in the protein-protein inter-
action network (PIN). We therefore reconstructed the
innate immunity PIN using the protein interactions from
the BioGRID database.51 As previously observed in other
protein interaction networks,42,66,67 we observed a nega-
tive correlation between degree centrality and f values,
with genes located in the center of the network (mostly
signal transducers and transcription factors) presenting
the strongest selective constraints (Figure 1D). Interest-
ingly, a stronger negative correlation was observed for
IIG products than for the remainder of protein-coding
genes (R ¼ 0.341 and 0.186, respectively; p ¼ 3.56 3
104), suggesting a crucial role of network topology in
driving the specific evolution of genes involved in innate
immunity.
Identification of Regions Presenting High-Confidence
Signals of Positive Selection
We next searched for IIGs that present signals of
recent, population-specific positive selection, because
they should contain variation that has contributed to
human adaptation to varying environments. To do so,
we restricted our analyses to (1) one population per
geographic region—Yoruba from Nigeria (YRI), Northern
Europeans (CEU), Han Chinese from Beijing (CHB)—and
(2) the low-coverage dataset of the 1000 Genomes Proj-
ect, because we needed to go beyond exonic regions to
compute statistics based on extended haplotype homozy-
gosity (Material and Methods). The low coverage (~53)
of this dataset has been shown to have little impact
on the power of some statistics to detect positive se-
lection.57
To detect signals of local adaptation, we used a compos-
ite method, the Fisher’s combined score (FCS), because
using composite methods has been shown to increase
power and minimize the detection of false positive
signals.5,55,68 We combined statistics based on haplotype12 The American Journal of Human Genetics 98, 5–21, January 7, 201homozygosity (iHS, DiHH, and XP-EHH), intra-allelic
haplotype diversity (DIND), and population differentia-
tion (DDAF and FST). We first assessed the power of FCS
by conducting a simulation-based study (Figure 2), which
considered accepted demographic scenarios for the popu-
lations studied. We found that the power of FCS was com-
parable to that of the composite of multiple signals
(CMS) test.5 Furthermore, the power of FCS, which is not
affected by the inclusion or removal of highly correlated
statistics (Figure S7), declines with the age of selection,
particularly among non-Africans (Figures 2 and S8). This
indicates that FCS tends to favor the detection of recent
events of positive selection (i.e., <30 kya).
At the genome-wide level, among SNPs displaying
multiple selection signals, we found a significant enrich-
ment in genic with respect to non-genic regions (OR > 1,
p < 104; Table S2), as previously reported.5,57 That no
significant enrichment in SNPs located in IIGs was
observed among SNPs with multiple selection signals,
nor among the different categories of innate immunity
genes (data not shown), suggests that positive selection
has not targeted IIGs to a greater extent than the
remainder of the genome (Table S2). However, we identi-
fied a set of IIGs presenting strong signatures of positive
selection, by looking at gene regions with a high clus-
tering of SNPs presenting selection signals.5,13,57 Specif-
ically, we searched for 100-kb windows with the highest
(top 1%) proportions of SNPs with extreme FCS values,
and found 1,110 (YRI), 670 (CEU), and 1,229 (CHB) of
such sliding windows, corresponding to 21, 16, and 22
genes, respectively (Table 2). We retrieved several already
reported signals of positive selection, including TLR6-
TLR1-TLR10 (MIM: 605403, 601194, 606270), IL4
(MIM: 147780), IFIH1 (MIM: 606951), CD36 (MIM:
173510), and CEACAM1 (MIM: 109770),5,8,14,36,38,69,70
but also a number of previously uncharacterized hits
(Table 2).
To fine-map the candidate variants underlying the posi-
tive selection signals, we merged the SNPs from the low-
coverage and exome high-coverage datasets for each of
the 57 candidate genes, considering also their flanking re-
gions (1 Mb upstream and downstream). The incorpora-
tion of the exome data allows detection of variants that
have failed to pass the quality-control filters and are
missing in the low-coverage data, e.g., the known func-
tional non-synonymous SNP rs5743618 in TLR1
(GenBank: NM_003263.3; c.1805G>T [p.Ser602Ile]).14
We re-computed the FCS statistics on this merged dataset
and determined the variants that exhibited the strongest
selection signals (1% variants with highest FCS; dark blue
dots in Figure 3). Focusing on coding variation, we identi-
fied 13 high-scoring variants (12 non-synonymous vari-
ants and 1 stop mutation) in 11 genes (Table 2 and
Figure 3), some of which have been previously identified
as adaptive mutations, e.g., rs5743618 in TLR114
(GenBank: NM_003263.3; c.1805G>T [p.Ser602Ile]),
rs10930046 in IFIH136,38 (GenBank: NM_022168.3;6
Figure 2. Power of the Fisher’s Combined Score to Detect Positive Selection
We simulated 200-kb DNA regions according to accepted scenarios of human demography for West African (YRI), European (CEU), and
East Asian (CHB) samples (see Material and Methods and Grossman et al.5). We simulated positive selection models, in each population
separately, using various ages (t) of the selected allele (5 kya, 10 kya, 20 kya, and 30 kya) and current frequencies (psel) of the selected allele
(0.2, 0.4, 0.6, 0.8, and 1.0), and setting the selection coefficient s to be equal to 0.01 (100 datasets for each parameter combination, see
Material and Methods). For each population, we plot the power (i.e., the proportion of simulated regions under positive selection effec-
tively detected) obtained with the FCS as well as, for comparison, FCS_DIND (i.e., FCS removing the DIND statistics), iHS, and XP-EHH
(see Material and Methods, FPR of 1%). For a detailed comparison of the differences in power of the FCS with respect to different com-
binations of neutrality statistics, see Figure S7. Left panels show, for each population, the power obtained with ages of selection t uni-
formly distributed from 5 kya to 30 kya. Smaller right panels display, for each population, the power obtained with ages of positive
selection of 5 kya, 10 kya, 20 kya, and 30 kya, respectively. The x axis represents the current frequency of the selected allele psel.c.1379A>G [p.His460Arg]), and rs3211938 in CD3670
(GenBank: NM_000072.3; c.975T>G [p.Tyr325Ter]).
Finally, we explored the involvement of the 57 candi-
date genes in diseases or traits by using GWAS and eQTL
data. We found that 27 of them have been associated, toThedifferent extents, with common diseases, including
susceptibility to infections or autoimmune disorders
(enrichment resampling p ¼ 3.77 3 104, 3.71 3 102,
and 0.058 in YRI, CEU, and CHB populations, respectively,
compared to all IIGs; Table S3). For 13 of these genes, weAmerican Journal of Human Genetics 98, 5–21, January 7, 2016 13
Table 2. Innate Immunity Genes Showing the Strongest
Signatures of Positive Selection
Population Innate Immunity Genesa
YRI VSP45, CD1D, FCER1A, LTBP1, CCDC88A, LY75,
IFIH1, LTF, CCR2, CD80, MAPK10, CD36,b ZFPM2,
TRIM55, CHUK, DAK, POLR3B, HIF1A, CEACAM1,
TNRC6B, MYH9
CEU CCDC88A, TLR10, TLR1, TLR6,MAP3K1, IL4, IRGM,
TRIM27, EYA4, ARPC1A, ZC3HAV1, SRPK2,
SMARCA2, SIRT1, DUOX1, ADAM10
CHB ARHGEF2, ADAM15, LYST, PELI1, ACTR2, MERTK,
ERBB4, SP100, RAF1, LRRFIP2, CLEC3B, RHOA,
GAB1, FER, ITPR3, EGFR, BLK, NRG1, SIRT1, OTUB1,
ARHGEF7, PIAS4
aThese genes overlap with at least one 100-kb window with the 1% highest
proportions of outlier SNPs with the highest FCS values. Note that larger genes
have a higher probability to be attributed to a selection signal (regardless of
whether this is a true or false signal), with respect to small genes. Genes that
are underlined contain at least one non-synonymous mutation with an outlier
FCS value: IFIH1: rs10930046 (GenBank: NM_022168.3; c.1379A>G [p.Hi-
s460Arg]); LTF: rs60938611 (GenBank: NM_001199149.1; c.446C>T
[p.Ala149Val]); ZFPM2: rs11993776 (GenBank: NM_012082.3; c.1208C>G
[p.Ala403Gly]); DAK: rs2260655 (GenBank: NM_015533.3; c.553G>A
[p.Ala185Thr]); TLR1: rs5743618 (GenBank: NM_003263.3; c.1805G>T
[p.Ser602Ile]) and rs4833095 (GenBank: NM_003263.3; c.743A>G
[p.Asn248Ser]); TLR6: rs5743810 (GenBank: NM_006068.2; c.745T>C
[p.Ser249Pro]); MAP3K1: rs702689 (GenBank: NM_005921.1; c.2416G>A
[p.Asp806Asn]); MERTK: rs7604639 (GenBank: NM_006343.2; c.1397G>A
[p.Arg466Lys]) and rs2230515 (GenBank: NM_006343.2; c.1552A>G
[p.Ile518Val]); CLEC3B: rs13963 (GenBank: NM_003278.2; c.316G>A
[p.Gly106Ser]); and NRG1: rs3924999 (GenBank: NM_001159995.1;
c.50G>A [p.Arg17Gln]).
bCD36 contains an outlier premature stop mutation (rs3211938, GenBank:
NM_000072.3; c.975T>G [p.Tyr325Ter]).also identified a strong correlation between our candidate
SNPs for positive selection and GWAS best hits (Table S4).
In addition, we found that SNPs at 30 of the 57 genes
were significantly associated with the expression of sur-
rounding genes (Table S5), based on eQTL data from
monocytes activated with various immune stimuli.62 We
therefore provide a list of high-confidence genes andmuta-
tions that might have conferred a selective advantage for
local adaptation to specific human populations.Estimating the Age of Genetic Adaptations Targeting
Innate Immunity
We next aimed to estimate the age, t, at which positive
selection has targeted the high-scoring coding variants
described above (Table 2), using an ABC framework.63 We
first checked the accuracy of the ABC estimations and
tested the performance of various sets of summary statis-
tics (Material and Methods) with different ABC methods
(i.e., ridge and neuralnet), using simulated datasets (Table
S6). As previously reported,64 we observed some overesti-
mations of t, e.g., the best relative estimation bias (rEB)
being around 0.3 when using the ‘‘set 2 of summary statis-
tics.’’ We therefore aimed to improve our ABC estimations
and found that the best estimations were obtained when
including arithmetic transformations of the summary
statistics.65 Specifically, when implementing the boosted-
neuralnet method, we obtained the greatest accuracy, i.e.,
lowest relative estimation bias (rEB) and lowest prediction14 The American Journal of Human Genetics 98, 5–21, January 7, 201error (PE) (see ‘‘set 3 of summary statistics’’ in Table S6). We
also noticed that the estimations of t are more accurate for
more recent events of positive selection, as expected when
considering that the power to detect selection decreases
with the age of selection (Figure S9 and Table S7).
We used the boosted-neuralnet method to estimate
the age of selection for the C/T-13910 polymorphism
(rs4988235, GenBank: NM_005915.5; c.1917þ326C>T)
in the LCT (MIM: 603202) region, the most iconic case
of positive selection in Europeans associated with lactase-
persistence in adulthood.71–73 We found an estimated age
(7,100 years; 95% CI: 3,500–11,000; Table S8 and
Figure S10) in good agreement with previous reports
(8,000 years in Tishkoff et al.,73 7,400 years in Itan
et al.,72 and 11,200 in Peter et al.64). We therefore applied
this procedure to estimate the selection ages for the 13
high-scoring coding variants at IIGs. In all cases, selection
events were dated at ~6,000–13,000 years ago (Table S8 and
Figures S11–S13) with a few exceptions. The most recent
selection events were estimated at less than 3,900 years,
for CD36 in Africans and NRG1 (MIM: 142445) in Asians,
and the oldest was found at 35,500 years for CLEC3B
(MIM: 187520) in Asians.
Investigating Neandertal Ancestry of Innate
Immunity Genes
Recent studies of individual loci have shown that adaptive
immunity genes such as HLA or innate immunity genes
such as STAT2 andOAS carry haplotypes inmodernhumans
that appear to have introgressed from archaic popula-
tions.23–25 In light of this, we evaluated, at the genome-
wide level, the extent to which modern humans have
acquired variation at IIGs via ancient admixture. We first
assessed the degree of Neandertal ancestry among IIGs as
a whole, taking advantage of the Neandertal introgression
map.22 We found that IIGs have a higher average introgres-
sion score when compared to the remainder of the coding
genome, in both Europeans and Asians (p ¼ 8 3 106
and p ¼ 2 3 106, respectively; Figure 4A). Notably,
these results were also significant when considering the
different European and Asian subpopulations individually
(p% 1.8 3 105 in all subpopulations). This result cannot
be accounted for by the strong selective constraint detected
at IIGs, because this selective regimehas been associated to a
decrease in Neandertal ancestry.22
Next, we determined the 5% of genes genome-wide
harboring the highest probability of Neandertal ancestry
in each population and searched for those corresponding
to IIGs. Out of the sets of 810 genes presenting the highest
introgression scores, we found 76 and 78 IIGs in Europeans
and Asians, respectively, 28 of which were shared between
the two groups (Table S9). Among these genes, we found
theOAS gene cluster, as previously documented by a candi-
date gene study.25 Importantly, we detected additional
regions involved in innate immunity, including genes en-
coding receptors such as NLRC5 (MIM: 613537) in Asians,
transcription factors such as IRF6 (MIM: 607199) in Asians,6
Figure 3. Innate Immunity Genes Pre-
senting High-Confidence Signals of
Geographic Adaptation
Four examples of innate immunity genes
presenting strong signals of positive selec-
tion, including (A) theTLR6-1-10 gene clus-
ter in CEU, (B) IFIH1 in YRI, (C) MERTK in
CHB, and (D) ZFPM2 in YRI. The black
curves delineate the proportions of outlier
SNPs (i.e., SNPs with the 1% highest FCS
values of the genome), within 100-kb re-
gions, at the genome-wide level, using the
low-coverage 1000 Genomes Project data-
set (see Material and Methods for details).
Blue dots represent the FCS value of each
SNP, calculated using the merged dataset
(both high- and low-coverage) for the fine
mapping of putative adaptive mutations.
Dark blue dots indicate SNPs with the 1%
highest FCS values of the genome, within
which non-synonymous variants are repre-
sented by red triangles. The remaining vari-
ants are plotted in light blue, where trian-
gles representnon-synonymousmutations.and effector molecules such as the IFITM1-3 (MIM:
604456, 605578, 605579) gene family in Europeans and
some type I IFNs in Asians.
Remarkably, two regions that we found to present high
Neandertal ancestry—the TLR6-TLR1-TLR10 gene cluster
and SIRT1 (MIM: 607199)—were also part of our high-con-
fidence genes under positive selection in Europeans and
Asians, respectively (Table 2). For these regions, we identi-
fied the SNPs that were most probably introgressed from
Neandertal22 (Figures 4B and 4C) and determined whether
they were correlated to candidate SNPs for positive selec-
tion. In SIRT1, introgressed haplotypes were not specif-
ically carrying any of our candidate SNPs, suggesting that
variation identified as under positive selection in modern
humans has not been acquired through archaic admixture.
For TLR6-TLR1-TLR10, haplotypes of inferred Neandertal
origin (16% in CEU and 49% in CHB) were tagged
by SNPs detected as targets of positive selection in Euro-
peans, including the non-synonymous SNP rs4833095 at
TLR1 (GenBank: NM_003263.3; c.743A>G [p.Asn248Ser]),
which is in partial LD (r2 ¼ 0.657) with the functional
rs5743618 variant (GenBank: NM_003263.3; c.1805G>T
[p.Ser602Ile]). However, the rs4833095 allele most
probably introgressed from Neandertal is not the puta-
tively selected derived allele (associated with protection
against asthma, allergy, and hay fever)74–76 but the ances-
tral, rare allele. These patterns suggest a much more com-
plex history than a single adaptive mutation transmittedThe American Journal of Humto Eurasians on a Neandertal haplo-
type background (Figures 4B and 4C).
Discussion
In this study, we have taken advan-
tage of whole-genome sequence data-sets to provide a comprehensive assessment of how selec-
tion, in its different forms and intensities, has driven the
evolution of innate immunity genes in humans. We
must point out that any definition of ‘‘innate immunity’’
is arbitrary and not exempt of ambiguity. Herein, our defi-
nition of innate immunity includes intrinsic, non-hemato-
poietic immunity, in addition to the traditional definition
of innate immunity as hematopoietic and non-adaptive.
Bearing this in mind, there are several important insights
that can be drawn from our study.
First, we show that innate immunity genes evolve under
stronger selective constraints than the remainder of pro-
tein-coding genes, indicating that the purge of deleterious
mutations has been particularly important in this gene
class. This observation is consistent with pathogens being
one of the most important long-time threats to human
survival.4,15 Furthermore, innate immunity is germline
encoded, unlike adaptive immunity whose variation is
mostly somatic,28,29 and ensures the sensing of pathogens
and the maintenance of homeostasis with symbiotic mi-
crobiota.27 Consequently, any mutation disturbing these
processes would be deleterious and rapidly eliminated
from the population. That the strength of selective con-
straints varies considerably among functional categories,
as well as among the different members within each, in-
forms us about the degree of redundancy or essentiality
of the corresponding genes. For example, among sensors,
the relaxed constraints of cytosolic RLRs attest to higheran Genetics 98, 5–21, January 7, 2016 15
Figure 4. Neandertal Ancestry of Innate Immunity Genes
(A) Comparison of the average introgression scores of innate immunity genes (IIGs) with respect to the remainder of protein-coding
genes (non-IIGs) in European (EUR) and East Asian (ASN) populations. ***p < 0.001 (see Material and Methods).
(B and C) Haplotypes of Neandertal ancestry in (B) CEU individuals at the TLR6-TLR1-TLR10 gene cluster and (C) CHB individuals at the
SIRT1 locus. Confidently inferred haplotypes of Neandertal ancestry, defined as long runs of SNPs that present a probability of Nean-
dertal ancestry> 0.9,22 are indicated in blue in each diploid individual from the 1000 Genomes Project. Red shadows highlight genomic
regions containing innate immunity genes.immunological redundancy,39 whereas the strong purify-
ing selection detected for the CNASs, similar to that of
endosomal TLRs,14 suggests that variation at these mole-
cules might be strongly deleterious for the host.
That genes evolving under strong purifying selection
are likely to fulfill essential, non-redundant functions in
host defense is supported by the observation that innate
immunity genes associated with autosomal-dominant
forms of primary immunodeficiencies present the stron-
gest evolutionary constraints (Figure S4). This is well illus-
trated by the cases of STAT1 (MIM: 600555) and TRAF3
(MIM: 601896),2 which are among the 1% most con-
strained of the genome (Table 1). Indeed, gain- and loss-
of-function mutations at STAT1 have been associated
with a range of immunological and clinical phenotypes,
including life-threatening and mild bacterial and viral
diseases, Mendelian susceptibility to mycobacterial dis-
ease, chronic mucocutaneous candidiasis, and autoimmu-
nity.77 Similarly, deficiency in TRAF3 has been associated
with herpes simplex virus 1 encephalitis, a devastating
infection of the central nervous system.78 These examples
support the notion that the genes we report as targeted by
strong purifying selection are of major biological rele-
vance in host survival. Given the pleiotropic functions
of many innate immunity genes, it is conceivable that
some of these genes might be involved in mechanisms
that can go beyond immunity, including housekeeping
functions. Regardless of the breadth of their biological
functions, mutations in highly constrained IIGs are likely
to predispose individuals to life-threatening disease;
combining next-generation sequencing and evolutionary
data in clinical studies should facilitate the discovery of16 The American Journal of Human Genetics 98, 5–21, January 7, 201novel genetic etiologies of severe, infectious disease
phenotypes.
Second, our study shows that innate immunity genes
have not undergone hard sweeps to a greater extent than
the remainder of the genome, supporting the notion that
polygenic adaptation has been pervasive among functions
related to innate immunity.79 However, we identify 57
genes presenting high-confidence signals of selective
sweeps in specific populations (Table 2). Most of the signals
detected in Europeans and Asians are accounted for by
nearly complete sweeps (mean selected allele frequency
of 67% [min 41%; max 88%] and 81% [min 31%; max
99%], respectively), whereas those identified in Africans
are largely explained by partial sweeps (mean 41% [min
22%; max 92%]). The general dearth of nearly complete
sweep signals in Africans is consistent with genome-wide
patterns,12,68,80 suggesting that increased drift and
geographic differences in selection pressures might have
inflated the number of nearly complete sweep signals
among non-Africans.80,81
Our age estimations show that most adaptations target-
ing coding variation at innate immunity genes have
occurred in the last 6,000–13,000 years. Some over-repre-
sentation of ‘‘young’’ positive selection events occurring
in the last 30,000 years is expected, because our simula-
tions show that the power of FCS tends to linearly decline
as the age of selection increases (Figures 2 and S8). Howev-
er, this decline was found to be moderate in African popu-
lations, suggesting that their enrichment in recent selec-
tion signals cannot be explained only by the power of
FCS. Despite the possible underestimation of older selec-
tion events, our estimated age ranges correspond well6
with the transition from food collection (hunting/gath-
ering) to food production (farming/herding) starting
10,000–13,000 years ago.82 In this context, a recent study
of West Eurasian ancient samples dating to between
8,500 and 3,000 years ago has detected strong signals of
positive selection at loci related to pigmentation, diet,
and immunity, supporting a scenario of Neolithic popula-
tions adapting to sedentary agricultural lifestyles.83 The
strongest selective signal they detect is the lactase persis-
tence allele, the origin of which we estimate at 7,100 years,
which reached appreciable frequencies in early farmers
(~10%) around 4,300 years ago. The shift to agriculture
was also accompanied by increased population density,
food crises, and contacts with cattle and biological wastes,
which modified human exposure to pathogens84 and, as
our results suggest, was associated to some degree of ge-
netic adaptation.
Several of our high-scoring positively selected genes
have been associated with common infectious, inflamma-
tory, or autoimmune phenotypes (Table S3) and contain
variants that have been previously detected as evolving
adaptively in specific populations; e.g., IFIH1 and CD36
in Africans, the TLR6-TLR1-TLR10 cluster in Europeans,
and BLK (MIM: 191305) in Asians.5,8,14,36,38,69,70 The case
of the stop mutation Thr1264Gly at CD36 (rs3211938,
GenBank: NM_000072.3; c.975T>G [p.Tyr325Ter]) is
particularly worth discussing. CD36 is an archetypal
pattern recognition receptor that mediates cytoadherence
of Plasmodium falciparum-parasitized erythrocytes.85,86
Although the association between CD36 and malaria re-
mains complex,70,87 the stop variant represents a well-sup-
ported case of positive selection,70,88 which our analysis
confirms, reaching a frequency of 29% in the Yoruba
fromNigeria. It has been proposed that the high frequency
of this variant in Nigeria results from a geographically
confined selective event.70 That we estimate the age of
the stop variant at only 3,600 years (95% CI:
2,125–5,025 years) strongly supports the notion that the
increase in frequency of this mutation restricted to west-
central Africa represents a local, recent, and strong event
of genetic adaptation. Investigating the association be-
tween CD36 and malaria phenotypes specifically in Niger-
ian populations is now needed.
Importantly, our list of positively selected candidate
genes includes hits that have not been previously detected
as targets of selection but contain SNPs that are associated
with immunity-related phenotypes (Tables S3 and S4).
Notably, we have detected two high-scoring non-synony-
mous mutations in MERTK ([MIM: 604705], rs7604639,
GenBank: NM_006343.2; c.1397G>A [p.Arg466Lys],
and rs2230515, GenBank: NM_006343.2; c.1552A>G
[p.Ile518Val]; Figure 3C), with a derived allele frequency of
79% in the Asian population. Interestingly, variation at
MERTK, a member of the 3 TAM receptor tyrosine kinases
that are involved in the regulation of inflammatory
responses, has been associated with hepatitis C-induced
liver fibrosis.89 Likewise, our analysis suggests that positiveTheselection has increased the frequency to 58% in Africans of
a non-synonymous mutation in ZFPM2 ([MIM: 603693],
rs11993776, GenBank: NM_012082.3; c.1208C>G
[p.Ala403Gly]; Figure 3D). ZFPM2 modulates the activity
of GATA transcription factors at the HAMP (MIM: 606464)
promoter, an antimicrobial peptide involved in the meta-
bolismof iron,which is critical forMycobacterium tuberculosis
growth in macrophages.90 Variation at ZFPM2 has been
recently suggested to be associated with susceptibility to
tuberculosis in a South African admixed population.91 Alto-
gether, we provide a tractable list of high-scoring selected
coding variants for experimental follow-up, which are likely
to have played a dominant role in recent adaptations of hu-
man populations to their respective environments.
Finally, our study provides insight into the degree of
introgression of innate immunity genes from archaic hom-
inins. It has been shown that protein-coding genes are
generally depleted in Neandertal ancestry, owing to the
widespread effects of negative selection against Neandertal
ancestry in gene regions.22 Interestingly, we find that
innate immunity genes present a higher average probabil-
ity of Neandertal ancestry than the remainder of the
coding genome. Among the genes presenting the highest
Neandertal ancestry we find the IFITM1-3 proteins (Table
S9), a family of restriction factors that restrict the replica-
tion of multiple viruses in vitro, including influenza A,
dengue, and West Nile.92 In particular, variation at IFITM3
has been suggested to alter the morbidity and mortality
associated with influenza infection in humans.93 That
innate immunity genes present evidence of both strong
purifying selection and high Neandertal ancestry suggests
either a weaker purge or a slightly stronger selective advan-
tage of Neandertal alleles in innate immunity genes in
Eurasian populations.
Our analyses suggest that neutral introgression is the
most likely explanation for innate immunity genes pre-
senting high Neandertal ancestry, because virtually none
of them present any positive selection signal in modern
humans. However, this lack of adaptive introgression
signals could be also explained by the limited power of
the FCS statistics to detect old selection events and,
most importantly, other selective regimes, such as poly-
genic adaptation or selection on standing variation. For
example, alleles introgressed from archaic hominins prob-
ably had a substantial population frequency when positive
selection started to act on them in modern populations.
This emphasizes the need to extend our study by
including, and developing, statistics empowered to detect
more subtle models of positive selection.
Despite this potential limitation, the case of the
TLR6-TLR1-TLR10 cluster is particularly worth discussing.
First, it presents high Neandertal introgression scores in
both Europeans and Asians (Figure 4B and Table S9). Sec-
ond, TLR6-TLR1-TLR10 has been proposed to be a hotspot
of positive selection in human and non-human pri-
mates.94 Third, this gene region, here and elsewhere, is de-
tected as a strongly supported case of local adaptation inAmerican Journal of Human Genetics 98, 5–21, January 7, 2016 17
Europeans (Table 2).14,41,95 Further support for the adap-
tive significance of TLR6-TLR1-TLR10 comes from ancient
DNA data, where this gene cluster appears to be among
the strongest signals of selection detected.83 Furthermore,
three high-scoring adaptive non-synonymous mutations
have been detected in this region (Figure 3A), one of
which (rs5743618 in TLR1, GenBank: NM_003263.3;
c.1805G>T [p.Ser602Ile]) appears to be the genuine target
of selection; it remarkably impairs agonist-induced NF-kB
activation by up to 60% and is linked to infectious disease
phenotypes, such as leprosy.14,41,96,97 However, this hypo-
responsiveness allele is not present in the Neandertal ge-
nomes.98 More generally, for SNPs most probably intro-
gressed from Neandertal that show signatures of positive
selection in Europeans, the alleles present in archaic hom-
inins are rare and ancestral in modern humans, whereas
positive selection has targeted the frequent, derived
alleles. Altogether, although we provide compelling evi-
dence supporting both high Neandertal ancestry and pos-
itive selection for functional mutations at TLR6-TLR1-
TLR10, our analyses show that Neandertal introgression
is probably not the source of such adaptive variation.
Future studies should experimentally test whether the
Neandertal-introgressed variation detected at this gene
cluster has any functional impact on TLR-mediated im-
munity to infection.
In summary,our analyseshave shownthat thecontempo-
rary diversity of innate immunity genes in humans results
from the intermingling of different demographic and selec-
tive events, including introgression from Neandertal, hard
sweeps at some loci in specific human populations occur-
ring mostly during the Neolithic transition, and continued
selective constraints at other loci. In doing so, they increase
our understanding of the degree of essentiality and adapt-
ability of innate immunity genes, with several candidates
for having played a dominant role in recent adaptations,
and provide insight into the extent to which modern hu-
mans might have acquired variation at innate immunity
genes through admixture with archaic hominins.Supplemental Data
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